Skip to main content
PhoenixBio Co.,Ltd. logo

PhoenixBio Co.,Ltd. — Investor Relations & Filings

Ticker · 6190 ISIN · JP3803010002 T Professional, scientific and technical activities
Open in API
Filings indexed 63 across all filing types
Latest filing 2016-11-14 Interim / Quarterly Rep…
Country JP Japan
Listing T 6190

About PhoenixBio Co.,Ltd.

https://phoenixbio.co.jp/

PhoenixBio is a contract research organization (CRO) specializing in translational animal models for the pharmaceutical industry. The company's core product is the PXB-mouse®, a proprietary chimeric mouse model featuring a liver that is highly repopulated (over 70%) with functional human hepatocytes. This humanized liver model is utilized globally in preclinical studies to evaluate drug metabolism, pharmacokinetics, and toxicity. In addition to supplying the PXB-mouse® and primary human hepatocytes (PXB-cells®), PhoenixBio provides comprehensive, quality-controlled contract study services to support drug discovery and early development projects.

Recent filings

Filing Released Lang Actions
四半期報告書－第16期第2四半期(2016/07/01－2016/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a '第２四半期報告書' (Second Quarter Report) for PhoenixBio Co., Ltd., covering the period from April 1, 2016, to September 30, 2016. It contains detailed financial statements, including the balance sheet, income statement, cash flow statement, and notes to the financial statements, as required by the Financial Instruments and Exchange Act of Japan. Since it is a comprehensive financial report for a period shorter than a full fiscal year and contains actual financial data, it is classified as an Interim/Quarterly Report. H1 2017
2016-11-14 Japanese
四半期報告書－第16期第1四半期(2016/04/01－2016/06/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for PhoenixBio Co., Ltd. covering the first quarter of the 16th fiscal period (April 1, 2016 to June 30, 2016). It contains detailed financial statements, including the balance sheet, income statement, and comprehensive income statement, as well as notes to the financial statements. It is a comprehensive financial report for a period shorter than a full fiscal year, which fits the definition of an Interim/Quarterly Report (IR). Q1 2016
2016-08-12 Japanese
有価証券報告書－第15期(2015/04/01－2016/03/31)
Annual Report Classification · 100% confidence The document is a 'Yuka Shoken Hokokusho' (Annual Securities Report) filed in Japan. It contains comprehensive financial statements, management discussion, and business overview for the fiscal year ending March 31, 2016. This document is the Japanese equivalent of a 10-K filing, which is the standard annual report for publicly traded companies. FY 2016
2016-06-29 Japanese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.